Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Nov 2025 for Nautilus Biotechnology, Inc., €5,184. Read the official filing
Filing timeline
BuySaleKentaro Suzuki
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kentaro Suzuki: trading record in brief
One trade, one date: on 10 November 2025, Kentaro Suzuki disclosed an open-market purchase of €5,184 in Nautilus Biotechnology, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kentaro Suzuki
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
4,000 shares@ US$1.49Common StockSEC:0002037191-25-000004:0
Canonical exit: 4 Feb 2026 (T+90)
1 of 1 declaration
